Analysts have set 12-month price targets for Kulicke & Soffa Indus, revealing an average target of $46.4, a high estimate of $57.00, and a low estimate of $35.00. This current average has increased by ...
Hinge Health (NYSE: HNGE) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their ...
Company Continues Portfolio Optimization on the Heels of Successful $72 million ACT Genomics saleCompany Maintains Strong Balance Sheet with over ...
NetBrands Corp., Delaware corporation (OTCID: NBND) (the “Company”), is advancing a hybrid digital asset mining strategy designed ...
NetBrands Corp., Delaware corporation (OTCID: NBND) (the "Company"), is advancing a hybrid digital asset mining strategy designed to diversify ...
HEICO's actual results may differ materially from those expressed in or implied by those forward-looking statements. Factors ...
IonQ’s investment thesis is neutral-to-bullish, supported by a full-stack platform strategy and a $1B-plus commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback